This webinar focuses on current regulatory expectations regarding the identification, investigation, and correction of deviations within firms, emphasizing the importance of an effective corrective and preventive action (CAPA) system. Participants will learn about FDA inspection observations related to inadequate investigations and how to implement corrective actions to prevent future issues. The session is beneficial for personnel in various quality and production roles, and includes opportunities for interactive engagement and certification of attendance.